Metformin-therapy effects in 50 clomiphene citrate resistant PCOS patients

Journal of Medical Sciences

Volumn 6, Issue 5, 2006, Pages 765-771

  Farzadi, L ^a   Salman Zadeh, S ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Metabolic disorders; Metformin; Ovulation

Indexed keywords

ANDROGEN; CHOLESTEROL; CLOMIFENE CITRATE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; METFORMIN; PLACEBO; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THIAMINE; TRIACYLGLYCEROL;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERANDROGENISM; MENSTRUAL CYCLE; METABOLIC DISORDER; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33845264359     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.765.771     Document Type: Article

References (24)

1. Azziz, R.A. and H. Zacur, 1995. Reproductive medicine and surgery. Mosby, USA., pp: 230-240.
2. Balen, A.H., J.S. Laven, S.L. Tan and D. Dewailly, 2003. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum. Reprod. Update, 9: 505-514.
3. Brindsen, R.P.A., 1999. Textbook of in vitro fertilization and Assisted Reproduction, 2nd Edn., The Parthenon Publishing Group, USA., pp: 380-400.
4. Carmina, E., T. Koyamat, L. Chang, F.Z. Stanczyk and R.A. Lobo, 1992. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resisitance in polycystic ovary syndrome? Am. I. Obstet. Gynecol., 167: 1801-1812.
5. Christine, A., B. Amy, H.U. Kathy, B. Melissa and C. John, 2003. Obese patients with polycystic ovary syndrome: Evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. J. Clin. Endocrinol. Metabol., 88: 5158-5162.
6. Crave, J.C., S. Fimbel, H. Lejeune, N. Cugnardey and H. Dechaud et al., 1995. Effects of diet and metformin administration on sex hormone-binding globulin androgens and insulin in hirsute and obese women. J. Clin. Endocrinol. Metabol., 80: 2057-2062.
7. David, S. and Guzick, 2004. Polycystic ovary syndrome. Fertil. Steril., 103: 181-182.
8. De Leo, V., A. la Marca and F. Petraglia, 2003. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocrine Rev., 24: 633-667.
9. Dunaif, A., K.R. Segal, D.R. Shelley, G. Green and A. Dobrjansky et al., 1992. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41:1251-1266.
10. Hung, E. and N. Mingsun, 2001. Effects of metformin on ovulation rate, hormonal and metabolic profiles in woman with clomiphene resistant polycystic ovaries: A randomized, double-blinded placebo controlled trial. Hum. Reprod., 16: 1625.
11. Kamini, R., 2001. The Infertility Manual, 1st Edn. Jaypee Brothers, New Delhi, pp: 235-245.
12. Kim, L.H., A.E. Taylor and R.L. Barbieri, 2000. Insulin sensitizers and polycystic ovary syndrome: Can a diabetes medication treat infertility? Fertil. Steril., 73: 1097-1098.
13. Lord, J. and T. Wilkin, 2004. Metformin in polycystic ovary syndrome. Curr. Opin. Obstet. Gynecol., 16: 481-486.
14. Moghetti, P., R. Castello, C. Negri, F. Tosi and F. Perrone et al., 2000. Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation. J. Clin. Endocrinol. Metabol., 85: 139-146.
15. Nestler, J.E., D.T. Jakubowicz, W.S. Evans and R. Pasquali, 1998. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N. Eng. J. Med., 335: 1867-1880.
16. Nestler, J.E., D.I. Jakubowicz, P. Reamer, R. Gunn and G. Allan, 1999. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N. Eng. J. Med., 340: 1314-1320.
17. Norman, R.J., R. Wu and M.T. Stankiewicz, 2004. Polycystic ovary syndrome. Med. J, Aust., 180: 132-137.
18. Norman, R.J., 2004. Editorial: Metfonnin - omparison with other therapies in ovulation induction in polycystic ovary syndrome. J. Clin. Endocrinol. Metabol., 89: 4801-4809.
19. Ortega, C., S. Luna, L. Hernández, G. Crespo and P. Aguayo et al., 2005. Responses of Serum Androgen and Insulin Resistance to Metformin and Pioglitazone in Obese, Insulin-Resistant Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metabol., 90: 1360-1365.
20. Palomba, S., F. Orio, N.L. Giovanni, A. Falbo and T. Russo et al., 2004. Metformin administration versus laparoscopic ovarian diathermy in clomiphene ctrate-rsistant wmen with plycystic oary sndrome: A pospective prallel randomized double-bind placebo-controlled trial. J. Clin. Endocrinol. Metabol., 89: 4801-4809.
21. Speroff, L.H.R.G. and N. Kase, 1999. Clinical Gynecologic Endocrinology and Infertility, 6th Edn., Williams and Wlkins, USA., pp: 391-397.
22. Vandermolen, D.T., V.S. Ratts, W.S. Evans, D.W. Stovall and S.W. Kauma et al., 2001. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil. Steril., 75: 310-315.
23. Velazquez, E.M., S. Mendoza, T. Hamer, F. Sosa and C.J. Glueck, 1994. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43: 647-654.
24. Wilshire, G.B. and N. Santoro, 1994. Appropriate Regimens Of pulsatile Gonadotropin-releasing Hormone (GnRH) Administration. In: Ovulation Induction: Basic Science and Clinical Advances, Filicori, M. and C. Flamigni (Eds.). Amsterdam, Excerpta Medica, pp: 245-253.